SCHEMBL7714124

SCHEMBL7714124

Nc1ncc(Oc2ccc(F)cc2)c(N2CCOCC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.44
MAPK1 P28482 1/20 0.44
PIK3CA P42336 7/20 0.44
AKT1 P31749 6/20 0.44
NOS1 P29475 1/20 0.43
DHFR P00374 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
PIK3CD O00329 1/20 0.42
PIK3R1 P27986 1/20 0.42
PIK3CG P48736 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GRIA1 P42261 1/20 0.41
CACNG2 Q9Y698 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8156197 0.94 MEN1 (0.48) MTORMAPK1PIK3CAAKT1NOS1
SCHEMBL7712416 0.88 MAPK1 (0.52) MTORMAPK1PIK3CAAKT1NOS1
SCHEMBL7714247 0.88 MEN1 (0.53) MTORPIK3CAAKT1NOS1DHFR
SCHEMBL7714121 0.87 PIK3CA (0.55) MTORPIK3CAAKT1NOS1DHFR
SCHEMBL7715853 0.85 DHFR (0.50) MAPK1DHFRNPC1RAB9ASMN1; SMN2
SCHEMBL7714141 0.80 SCN9A (0.47) DHFR
SCHEMBL7712422 0.78 STK4 (0.54) MTORPIK3CAAKT1DHFRPIK3CD
SCHEMBL14541937 0.75 KDM4E (0.69) MTORPIK3CANOS1DHFRPIK3CD
SCHEMBL7714150 0.73 MEN1 (0.61) MAPK1TRPM8ADORA2AKDM4E
SCHEMBL7712369 0.73 DHFR (0.50) MAPK1DHFRKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed